These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

123 related items for PubMed ID: 6097118

  • 1. Cefmenoxime therapy in bacterial osteomyelitis.
    Sheftel TG, Cierny G, Lefrock JL, Mader JT.
    Am J Med; 1984 Dec 21; 77(6A):17-20. PubMed ID: 6097118
    [Abstract] [Full Text] [Related]

  • 2. Clinical efficacy and safety of cefmenoxime in children.
    Tansino GF, Hammerschlag MR, Congeni BL, Cox PA, Doraiswamy B, duBouchet L.
    Antimicrob Agents Chemother; 1985 Oct 21; 28(4):508-10. PubMed ID: 3865630
    [Abstract] [Full Text] [Related]

  • 3. Cefmenoxime: clinical evaluation.
    Baker RL, Perkins RL.
    Am J Med; 1984 Dec 21; 77(6A):53-9. PubMed ID: 6097126
    [Abstract] [Full Text] [Related]

  • 4. Comparative evaluation of cefmenoxime versus cefoxitin in serious infections.
    Bechard DL, Hawkins SH, Sutherland SC.
    Am J Med; 1984 Dec 21; 77(6A):13-6. PubMed ID: 6097117
    [Abstract] [Full Text] [Related]

  • 5. Clinical experience with cefotaxime in the treatment of serious bone and joint infections.
    LeFrock JL, Carr BB.
    Rev Infect Dis; 1982 Dec 21; 4 Suppl():S465-71. PubMed ID: 6294800
    [Abstract] [Full Text] [Related]

  • 6. Cefmenoxime. Clinical, bacteriologic, and pharmacologic studies.
    LeFrock JL, Molavi A, McCloskey RV, Rolston K, Chandrasekar P, Henao L, Smith BR, Kannangara W, Schell RF, Carr BB.
    Am J Med; 1984 Jul 21; 77(1):72-8. PubMed ID: 6331163
    [Abstract] [Full Text] [Related]

  • 7. [Experimental and clinical studies of cefmenoxime in the field of obstetrics and gynecology].
    Takase Z, Noda K, Hayasaki M, Iwasa S, Motomura R, Yamabe T, Ichinohe K, Kutsuzawa T, Kaneko M, Domon H, Kodama M, Shimizu T, Mizoguchi H, Yorozu Y, Maki M, Chimura T, Matsuda S, Cho N, Fukunaga K, Kunii K, Wagatsuma T, Kaku R, Hogaki M, Ikawa M, Matsumoto Y, Fukuoka H, Honma T, Sanada K, Minakuchi H, Sumiyoshi Y, Hayashi S, Nakamura H, Goto T, Ihara Y, Hagiwara K, Tsuruta S, Yabuki A, Higashide K, Hasegawa Y, Ninomiya K, Okada H, Kanao M, Yasuda J, Takashima E, Ikeuchi M, Kobayashi Y, Haruta T, Hirabayashi K, Doko F, Watanabe K.
    Jpn J Antibiot; 1982 Jun 21; 35(6):1585-609. PubMed ID: 6290708
    [Abstract] [Full Text] [Related]

  • 8. [Clinical evaluation of cefmenoxime in chronic complicated urinary tract infection].
    Ashiki A, Sudo Y, Suzuki T, Yamato K, Tsukui A, Hamada W, Kusumi Y.
    Jpn J Antibiot; 1985 Jan 21; 38(1):49-61. PubMed ID: 3857363
    [Abstract] [Full Text] [Related]

  • 9. Cefmenoxime therapy for gynecologic and obstetric infections.
    Rao B, Savage EW, Chuah SK, Bansal MB, Dhawan VK, Thadepalli H.
    Obstet Gynecol; 1985 Sep 21; 66(3):377-83. PubMed ID: 3860790
    [Abstract] [Full Text] [Related]

  • 10. Cefmenoxime: in vitro activity.
    Stamm JM.
    Am J Med; 1984 Dec 21; 77(6A):1-3. PubMed ID: 6097114
    [Abstract] [Full Text] [Related]

  • 11. Bone and joint infections caused by gram-positive bacteria: treatment with cefotaxime.
    LeFrock J, Mader J, Smith B, Carr B.
    Infection; 1985 Dec 21; 13 Suppl 1():S50-5. PubMed ID: 4055056
    [Abstract] [Full Text] [Related]

  • 12. [Clinical laboratory approach for estimating effective administrative dosage of cefmenoxime. Observation on the MICS and cefmenoxime disc susceptibility test].
    Uete T, Matsuo K.
    Jpn J Antibiot; 1984 May 21; 37(5):791-801. PubMed ID: 6090721
    [Abstract] [Full Text] [Related]

  • 13. [Clinical evaluation of cefmenoxime in urinary tract and prostatic infections].
    Guibert J, Acar JF, Destree D, Bryskier A.
    Pathol Biol (Paris); 1985 May 21; 33(5):330-4. PubMed ID: 3897962
    [Abstract] [Full Text] [Related]

  • 14. [Clinical evaluation of cefmenoxime (CMX) for complicated urinary tract infection].
    Tsuchida S, Sasaki S, Takada H, Miyagata S, Sato S, Shimizu S, Sakamoto F, Kizu N.
    Hinyokika Kiyo; 1985 Feb 21; 31(2):365-74. PubMed ID: 3859998
    [Abstract] [Full Text] [Related]

  • 15. Cefmenoxime therapy of serious bacterial infections.
    Gombert ME, Glasser LA, Eng RH.
    Antimicrob Agents Chemother; 1984 Apr 21; 25(4):510-2. PubMed ID: 6329082
    [Abstract] [Full Text] [Related]

  • 16. Cefmenoxime efficacy, safety, and pharmacokinetics in critical care patients with nosocomial pneumonia.
    Schentag JJ, Reitberg DP, Cumbo TJ.
    Am J Med; 1984 Dec 21; 77(6A):34-42. PubMed ID: 6097122
    [Abstract] [Full Text] [Related]

  • 17. Clinical results and concentrations of cefmenoxime in serum, amniotic fluid, mother's milk, and umbilical cord.
    Weissenbacher ER, Adams D, Gutschow K, Peters-Welte C, Luehr HG.
    Am J Med; 1984 Dec 21; 77(6A):11-2. PubMed ID: 6097116
    [Abstract] [Full Text] [Related]

  • 18. [In vitro bacteriostatic activity of cefmenoxime (SCE 1365), cefotaxime and moxalactam].
    Husson MO, Bryskier A, Izard D, Leclerc H.
    Pathol Biol (Paris); 1983 May 21; 31(5):347-50. PubMed ID: 6312395
    [Abstract] [Full Text] [Related]

  • 19. Laboratory evaluation of cefmenoxime: a new cephalosporin. In vitro and in vivo antibacterial activities and pharmacokinetic properties.
    Matsumoto K, Nagatake T, Uzuka Y, Harada T, Rikitomi N.
    Chemotherapy; 1983 May 21; 29(2):80-8. PubMed ID: 6301776
    [Abstract] [Full Text] [Related]

  • 20. Cefotaxime therapy for patients with osteomyelitis and septic arthritis.
    Mader JT, LeFrock JL, Hyams KC, Molavi A, Reinarz JA.
    Rev Infect Dis; 1982 May 21; 4 Suppl():S472-80. PubMed ID: 6294801
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.